BRD-K92723993-066-04-5
HELA
maintaining cell culture
L1000-Phase2
cervical adenocarcinoma
datapackage.zip
LINCS
L1000 LINCS DCIC REP.A027 HELA 24H A22 imatinib 0.37um.tsv.gz
uterine cervix
Label
Description
A 123 KB file from LINCS produced from OBI:0002965 as part of the L1000 Phase2 project